Not currently the time of year, but spring is around the corner. Seems to be in the news every other week. Task forces being formed.

Similar documents
STATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA

Infectious Diseases Expert Group (IDEG) Department of Health and Wellness. Statement for Managing Lyme Disease in Nova Scotia

Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories

Tick Talk: What s new in Lyme Disease. May 5 th, 2017 Cristina Baker, M.D., M.P.H.

LYME DISEASE Last revised May 30, 2012

Lyme Disease. By Farrah Jangda

Lyme disease Overview

Lyme disease Overview

NO DISCLOSURES. Lyme Disease Convention and Controversies. Willie Burgdorfer, Ph.D. ( ) RM Lab in Hamilton, MT 1/20/2017

NO DISCLOSURES. Lyme Disease. Outline. Case. Case. Case 2/10/2014

NO DISCLOSURES. Lyme Disease. Outline. Case 4/16/2014. Richard A. Jacobs, MD, PhD.

My Case Study Solution

Ticks and Tick Borne Diseases

Lyme Disease. 1. DISEASE REPORTING A. Purpose of Reporting and Surveillance

Ticks & Tickborne Diseases of Minnesota. Vectorborne Diseases Unit Last Updated February 16, 2018

2/7/2018. Lyme Disease Convention and Controversies. Richard A. Jacobs, M.D., PhD. NO DISCLOSURES

Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014

Peter J. Weina, PhD, MD, FACP, FIDSA. Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research

Lyme Disease, an Infectious Diseases Perspective

SELECTED INFECTIONS ACQUIRED DURING TRAVELLING IN NORTH AMERICA. Lin Li, MD August, 2012

DOWNLOAD OR READ : TREATMENT OF CHRONIC LYME DISEASE FIFTY ONE CASE REPORTS AND ESSAYS PDF EBOOK EPUB MOBI

Understanding Chronic Lyme Disease. Kerry Lang November 5, 2017

Lyme Disease: Prevention, Recognition & Treatment

Virginia Department of Health. Attached are the publications on ticks and tick-borne diseases from the Department of Health s website.

Tick-borne Infections

Current Trends and Research in Vector-Borne Disease in New York State

Seroprevalence of Babesia microti in Individuals with Lyme Disease. Sabino R. Curcio, M.S, MLS(ASCP)

Public Statement: Medical Policy Statement:

Technical Bulletin No. 121

Lyme Disease and Tick Surveillance in British Columbia

Using administrative medical claims data to estimate underreporting of infectious zoonotic diseases

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute your phone.

Lyme Disease. (Borrelia burgdorferi) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS

Clue # 1: Before. After

Spatial Analysis of Lyme Disease in Howard County, Maryland

Tickborne Disease Case Investigations

Title: Public Health Reporting and National Notification for Lyme Disease

Corporate Medical Policy

Kathleen A. McGann, MD Pediatric Infectious Diseases Sea Pines CME Course, June 2017 Duke University Medical Center

LYME DISEASE. Page. Lyme Disease: Medical Policy (Effective 10/01/2013)

Tickborne Diseases: Challenges and Controversies

Lyme Neuroborreliosis

IDSA Survey: Outcomes Important to Lyme Patients Chartbook. Conducted March 26-April 25, 2015

Recognizing the Clinical and Laboratory Presentation of Human Granulocytic Anaplasmosis

Lyme disease stakeholder scoping workshop

LIMITING LYME DISEASE: USING SYSTEM DYNAMICS SIMULATION TO TARGET HEALTH INTERVENTIONS. Shilo Helen McBurney

Manitoba Annual Tick-Borne Disease Report

Lyme Disease: A Mathematical Approach

Mini Medical School for the Public

Emerging vector-borne diseases in the United States: What s next and are we prepared?

Massachusetts face to face with Lyme disease patient protection bill

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Supplementary Appendix

A Patient s Guide to Lyme Disease

Lyme disease conference

LYME DISEASE: NEW OPTIONS FOR TREATMENT

Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease

The Federal Tick-borne Disease Working Group and CDC's current activities on IPM for Lyme disease prevention and control

Nebraska Public Health Laboratory Newsletter

Addressing Tick Borne Diseases in Ireland. Dr. John Lambert - Professor of Medicine and Infectious Diseases, Mater Hospital & UCD School of Medicine

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis

Tickborne infections in Connecticut

the lyme diet 05C6AA30C457C5CC4F045DC84D04A422 The Lyme Diet 1 / 6

Lyme Disease. Abstract Lyme disease is a vector borne infection primarily transmitted by Ixodes ticks and. Special Issue

MP Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease. Related Policies None

Clinician Approaches to the Diagnosis of the Patient with Suspected Lyme Disease

Acute Lyme disease is a well known and recognized infection caused by the Borrelia burgdorferi spirochete and associated tick borne organisms.

Lyme Disease Diagnosis and Treatment

Jacquelyn A. Hakim 1 and Adenike Bitto 2. Abstract

Ring Forms in Red Blood Cells (RBCs) Babesia? from Danish Chronically Ill Patients, All Clinically Suspect of Having Persistent Active Borreliosis!

The Beginner's Guide to LYME DISEASE

Alberta Health Public Health Notifiable Disease Management Guidelines January 2013

Tickborne Disease in New Hampshire HEHNA Meeting Elliot Hospital September 27, 2017

Lyme disease is a bacterial infection. Even if successfully treated, a person may become reinfected if bitten later by another infected tick.

No Time for Lyme: Public Health Approaches to Lyme Disease in Vermont

Climate Change as a Driver for Vector-Borne Disease Emergence

Lyme disease in Canada: modelling,, GIS and public health action

History of Lyme Disease

A Patient s Guide to Lyme Disease

THIS IS AN OFFICIAL NH HEALTH ALERT

Manitoba Annual Tick-Borne Disease Report

The new england journal of medicine. The Clinical Problem

Issues in the Diagnosis and Treatment of Lyme Disease

Medical Review Criteria Lyme/Tick-Borne Diseases: Use of Parenteral Antibiotics

Registered Charity: "Encouraging awareness, prevention & treatment of Lyme Disease (Borreliosis) in Ireland."

Research Article Proof That Chronic Lyme Disease Exists

Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi Years after Active Lyme Disease

Practitioners often encounter

Working Group Practices and Composition

Human ehrlichiosis: clinical aspects and treatment. Eric Van Wijngaerden Universitaire Ziekenhuizen Leuven

Lyme disease is an uncommon, but not

Institute of Medicine Lyme Disease Teleconference Listening session for Georgia, South Carolina, North Carolina June 2, :00 p.m. 1:30 p.m.

An Analysis of Canadian Facebook Posts about Lyme Disease between 2012 and Nikhil Kumar

Clinical Policy Title: Lyme disease diagnosis and treatment

Case Report Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome

A Case of Optic Neuritis Secondary to Lyme Disease

2/5/19. Lyme Disease: It s Complicated! Lyme Disease is Worldwide. Lyme Disease: An Immune Response initiated by Borrelia burgdoferi

T H E F A C T S T H E C H A L L E N G E

Lyme disease conference

Disclosures. Ticked-off... Myths, Truths, and Realities of Tick-borne Infections including Lyme, Babesia, and Ehrlichia

Transcription:

1

2

3

Not currently the time of year, but spring is around the corner. Seems to be in the news every other week. Task forces being formed. Elizabeth May has been a big proponent. Avril Lavigne has come forward regarding her battle with Chronic Lyme. I do not disagree that we need to look into this further, but I am not a fan of how the media is painting physicians to be in their articles. We are portrayed as ignorant and uncaring, forcing patients to spend much of their hard earned money to seek diagnosis and treatment elsewhere. For a deeper look I suggest the documentary Under Our Skin. 4

Discovered in Lyme, Connecticut by Dr. Burgdorfer, investigating an abnormal cluster of juvenile RA. Other common tick-borne illnesses are transmitted through the lone star tick (Amblyomma americanum) and the American dog tick (Dermacentor variabilis) that transmit ehrlichiosis and Rocky Mountain spotted fever, respectively. The ticks serve as the vector between the animal population and humans. Deer are the preferred host for ticks, and the tick population is highest when deer are present, but the actually pick up the Borrelia from small mammals mostly. 5

Nymphs cause the majority of infections and a most efficient at transmitting the bacteria. Since they are small, they can feed longer and go undetected. 6

Millidgeville and North Head are the two listed Endemic areas on healthycanadians.gc.ca for New Brunswick. Nymphs may not have a well developed scutum and can be very small. Best to send all ticks for identification. 7

A) is an Argasid (soft tick, Ornithodoros turicata) B) has a scutum, long body but short mouth parts (dog tick, Dermacentor variabilis) C) is Ixodes scapularis (!) D) has a scutum, but has a short and stout body it also has a lone star on its body (lone star tick, Amblyomma americanum) 8

Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after an Ixodes scapularis Tick Bite. N Engl J Med. 2001;345(2):79-84. doi:10.1056/nejm200107123450201. This was in the late 90 s in Westchester New York, where Lyme is hyperendemic (ie. >20% local infection rate). Feldman et. al. put New York state endemic areas at 23 % local nymphal infection rate (2015, J of Vector Ecology). 9

Usual tick is about 3 mm in size, engorged tick can approach the size of a dime. 10

Majority of serology is negative in early stage, predominantly IgM if positive. Testing is not recommended at this point, just treat! The beef with our testing and not diagnosing early doesn t hold much weight, as antibody related testing is expected to be negative. In fact some patients if treated early will never sero convert at all (ie. no objective evidence of past infection). 11

12

Lots of variations, but all uniformally are large erythematous macules. 13

Serologic testing is universally positive at this point (>90%). Bilateral 7 th Cranial nerve palsies are practically diagnostic of Lyme disease. Think about Lyme disease and ask about tick exposure in patients with CN VII palsy, subacute meningitis, AV block or large joint effusions. 14

Serology remains positive for years, but will be IgG at this point. 15

Again the issues raised Lyme Advocacy groups only hold weight if you are using the tests inappropriately (ie. either in early acute phase when you should be treating (FN), or in vaque chronic symptoms with no hx of a tick bite/exposure (FP)). 16

The medias talk of the inadequacies of our tests are largely due to misunderstanding about how an antibody test works. They will quote up to 50% of cases missed, but this is in early stage, and not where this test is designed to be used. 17

**If patient has travelled to another country with endemic Lyme disease caused by an alternate Borrelia species, just specify this when submitting the test and they can perform specific testing for B. afzelii/garinii. 18

This scenario is unlikely, as by 4 weeks most have converted to a largely IgG response, IgM suggests active infection and would likely be there in isolation at 4 weeks or later. Consider testing if EM rash with no clear exposure, or initial negative Step 1 test with ongoing symptoms consistent with Lyme disease. Sensitivity goes up in convalescent phase. 19

5. From Branda, J et. al. (2010) in Clinical Infectious Disease. Canadian test uses C6 assay (C6 protein on conserved part of the Spirochete) in the Tier 1 test (CID 2008: 47: 188-195). Again this test is specific so its not churning out false positives in the early going. It becomes sensitive in later stages. SPIN (better at ruling in) SNOUT (better at ruling out) 20

CDC Algorithm for using the 2 Tier test. 21

IDSA guideline. Species identification not as useful, as generally they don t bring it in, or its mangled. I couldn't t find a true infection rate for Millidgeville, and since we only have 10-12 confirmed cases per year in the whole province it may be hard to say. As its listed as an endemic area I have been practicing under the assumption that it is greater than 20%. 22

23

Duration of 10-14 days is recommended. 24

25

General idea, oral for less severe, IV for more severe. 2 weeks for EM, up to 4 weeks for others. 26

CPS guidelines on Lyme Disease. 27

Cefotaxime is not listed in the CPS guidelines. Macrolides have poor efficacy against B. burgdorferi. Duration of treatment is essentially the same, 2-4 weeks depending on mild to severe manifestations, and IV for more severe disease. 28

Excerpt from lymedisease.org initial explanation of chronic lyme disease. This is a similar to what you will read in CanLyme and most other patient advocate or support websites. 29

PTLDS is an accepted subset of patients (10-20%), that have persistent fatigue, MSK pain, and subjective neuro symptoms for months to years after treatment with antibiotics. The consensus in the medical community is that they eventually get better with time and that the symptoms are attributable to auto-immune dysfunction. About 2 % of the general population also has symptoms similar to PTLDS (ie. CFS or Fibromyalgia) 30

The IDSA vs ILADS has spawned the Lyme Wars. 2014 Guidelines released by ILADS have made recommendations such as treating every tick bite patient regardless of attachment or endemic Lyme rates, with 3 weeks of antibiotics, using 3 weeks of treatment as a minimum duration, and retreating with 4-6 weeks of oral or possibly IV antibiotics for any return of symptoms, whether that be weeks/months/or years later. They also list such a myriad of symptoms, that you could attribute almost any constellation of symptoms to chronic Lyme. 31

Klempner 30 days Ceftriaxone, then 60 days Doxy, in both seropositive and negative patients previously treated for Lyme. Krupp 28 days of Ceftriaxone, improvement in only fatigue, but with significant adverse effects (3 hospitalizations). Fallon 10 weeks of Ceftriaxone, objective improvement at 12 weeks, no improvement at 24 weeks. Berende 2 weeks Ceftriaxone for all, then 12 weeks Doxy, Azithro, or placebo, no difference between 2 weeks or longer in symptoms. 32

Its very important we understand how our 2 Tier testing works in Canada, so that we are able to talk the talk with these patients. Most patients with EM will have negative serologic tests, and this shouldn't t be viewed as a weakness of our test, its not designed for early Lyme Disease with Erythema migrans. If they have erythema migrans, just treat them. 33

We need to approach these patients with an open, respectful, and caring dialogue. Stick to your principles about what you believe is best practice, but also take the time to listen to them, legitimize their symptoms, and try to help if you can (referrals, follow up, etc). If you go into these rooms with obvious preconceptions and attitude, they will sense it, and you will get no where with them. 34

There is some human and animal studies suggestive that chronic spirochete infection may exist, albeit mostly DNA fragments in tissue or urine, and how best to treat this and whether its linked to Chronic Lyme disease has not been studied, but we still need to keep an open mind. 35

False positives are highly likely in patients with low pre-test probability. 36

If a patient presents a positive test from a private lab, only look at the CDC criteria interpretation. 37

38

39

40

41